Depression is among the most researched areas in nutraceutical psychiatry — and the evidence is better than most people realize. A Cambridge University network meta-analysis identified a small group of supplements with consistent evidence as both monotherapy and adjuncts for depressive disorder. The three below made that list.
These are the supplements we discuss most often with appropriate patients at Florida Behavioral Health Associates and make available through our Fullscript dispensary. They're not replacements for clinical treatment of moderate-to-severe depression — but for the right patients, they're meaningful additions to a treatment plan.
1. High-EPA Omega-3 — The Best-Evidenced Supplement for Depression
Omega-3 fatty acids have one of the strongest and most consistent evidence bases of any supplement for depression — but most people don't know that the formulation matters enormously.
A meta-analysis of 26 RCTs (n=2,160) confirmed antidepressant effects of omega-3, with EPA-dominant formulations significantly outperforming DHA-dominant ones (SMD −1.03). EPA-only and EPA-major preparations at ≤1 g/day showed the most consistent antidepressant effects. As an adjunct to antidepressants, EPA+DHA combinations showed superior efficacy to antidepressants alone.
The mechanism involves anti-inflammatory pathways (neuroinflammation is increasingly understood as a contributor to depression), membrane fluidity in neuronal signaling, and monoamine modulation. It works best as an adjunct — and emerging evidence suggests particular benefit for patients with markers of inflammation, though this subgroup finding is still being replicated.
The omega-3 available in our dispensary is Nordic Naturals ProEPA Xtra — high-EPA, molecular distillation for purity, triglyceride form for superior absorption. This is the professional formulation, not the generic drugstore version.
Dose: 1–2 g EPA per day (≥60% EPA formulation). Minimum 8-week trial.
Caution: Use caution with anticoagulants at higher doses.
2. Saffron — The Most Underrated Supplement in Psychiatry
Saffron is the supplement most people are surprised by — and the one with arguably the most impressive clinical data in this category.
A meta-analysis published in Nutrition Reviews (Oxford) found saffron had a large positive effect size versus placebo for depressive symptoms (g = 0.99, P < 0.001). Multiple RCTs have shown comparable efficacy to antidepressants for mild-to-moderate depression — with significantly fewer side effects. This evidence does not extend to moderate-to-severe depression. The Cambridge network meta-analysis noted that saffron combined with an antidepressant had the highest efficacy ranking of all interventions tested (SMD 3.79).
The mechanism includes serotonin reuptake inhibition, dopamine and norepinephrine modulation, anti-inflammatory effects, and neuroprotection. It's not a spice in your food — it's a standardized extract at a therapeutic dose.
The formulation matters: you need a product standardized to lepticrosalide (≥3.5%) or using the Affron® extract — the form used in clinical trials. Products using this standardized extract are available through our Fullscript dispensary.
Dose: 30 mg/day (15 mg twice daily) of standardized extract. Most trials used 6–8 weeks.
Caution: Most evidence is in mild-to-moderate depression. Not recommended in pregnancy at therapeutic doses.
3. SAMe — Methylation Support and Antidepressant Augmentation
SAMe (S-Adenosyl-L-Methionine) is a naturally occurring compound in the body that serves as a methyl donor in the synthesis of serotonin, dopamine, and norepinephrine — the three monoamines most central to depression treatment.
SAMe is one of four nutraceuticals highlighted in the Cambridge network meta-analysis as having consistent evidence for depressive disorder. RCTs show it reduces depression scores as both monotherapy and as an augmentation strategy for antidepressant partial-responders — patients who are on medication but haven't achieved full response. Response rates are significantly higher than placebo, and some trials show comparable efficacy to tricyclic antidepressants.
The SAMe available in our dispensary is Pure Encapsulations SAMe 400, which uses the butanedisulfonate salt (the most stable, bioavailable form), is enteric-coated for gut protection, and is independently third-party tested.
Dose: 400–1,600 mg/day. Start at 400 mg/day and titrate up over 2–4 weeks to minimize GI side effects.
Important: SAMe is contraindicated in bipolar disorder — it can precipitate mania or hypomania. Do not use if you have bipolar disorder. SAMe also has serotonin syndrome risk when combined with antidepressants — discuss with your provider before combining.
Dealing with depression? Florida Behavioral Health Associates provides psychiatric evaluation and medication management for depression via telehealth throughout Florida. New patient appointments within 1–2 days. Book an appointment →
